Ф. Т. Агеев

2 ta ish

National Medical Research Center of Cardiology

1. Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement

   С. Н. Терещенко, М. В. Шестакова, Ф. Т. Агеев +7

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.282517

2. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment

   V. Y. Mareev, И. В. Фомин, Ф. Т. Агеев +26

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.621580